Synairgen (SNG)

 

Latest News

Broker Forecast - N+1 Singer issues a broker note on Synairgen PLC

N+1 Singer today reaffirms its buy investment rating on Synairgen PLC (LON:SNG) and cut its price target to 46p (from 4...

Synairgen widens H1 pretax loss

Synairgen has widened its H1 pretax loss to 1.7m, from a year-earlier loss of 1.0m. Revenue was nil, from 25,000. "We are ve...

Interim results for six months ended 30 June 2016

RNS Number: 5051K Synairgen plc 22 September 2016 Press release Synairgen plc ('Synairgen' or the 'Company') Interim results for the six months ended 30 June 2016 ~ Clinical development of AZD9412 with AstraZeneca on track and Pharmaxis collaboration progressing towards the clinic ~ Southampton, UK - 22 September 2016: Synairgen plc (LSE: SNG), the respir...

Notice of Interim Results

RNS Number: 2364J Synairgen plc 08 September 2016 PRESS RELEASE 8 September 2016 SYNAIRGEN PLC ("Synairgen" or "the Company") Notice of Interim Results Southampton, UK, 8 September 2016: Synairgen plc (LSE: SNG), the respiratory drug discovery and development company, will issue its interim results for the six-month period ended 30 June 2016 o...

All News

DateHeadlineSource
22-09-16Broker Forecast - N+1 Singer issues a broker note on Synairgen PLCStockMarketWire
22-09-16Synairgen widens H1 pretax lossStockMarketWire
22-09-16Interim results for six months ended 30 June 2016RNS
08-09-16Notice of Interim ResultsRNS
14-06-16Result of AGMRNS
07-06-16Are Synairgen plc or Immupharma plc better investments than AstraZeneca plc?Motley Fool
17-05-16Posting of Annual Report and Notice of AGMRNS
21-04-16Holding(s) in CompanyRNS
23-03-16Synairgen options exercised StockMarketWire
23-03-16Exercise of OptionsRNS
22-03-16Broker Forecast - finnCap issues a broker note on Synairgen PLCStockMarketWire
22-03-16Positive LOXL2 resultsRNS
22-03-16Preliminary results for the year ended 31 Dec 2015RNS
03-03-16Notice of Preliminary ResultsRNS
16-11-15Adoption of FRS 101 - Reduced Disclosure FrameworkRNS
13-11-15Holding(s) in CompanyRNS
13-11-15Holding(s) in CompanyRNS
13-11-15Holding(s) in CompanyRNS
12-11-15Director Deals - Synairgen PLC (SNG)StockMarketWire
12-11-15Director Deals - Synairgen PLC (SNG)StockMarketWire
12-11-15Director Deals - Synairgen PLC (SNG)StockMarketWire
12-11-15Director Deals - Synairgen PLC (SNG)StockMarketWire
12-11-15Directors' Share PurchaseRNS
28-10-15Grant of optionsRNS
16-09-15Synairgen swings to H1 pretax lossStockMarketWire
16-09-15Interim ResultsRNS
21-08-15Synairgen schedules interimsStockMarketWire
21-08-15Notice of Interim ResultsRNS
05-08-15Synairgen announces research collaborationStockMarketWire
05-08-15Synairgen announces research collaborationStockMarketWire
05-08-15Synairgen announces research collaborationRNS
22-07-15SNG says AstraZeneca beings Phase II Trial of AZD9412StockMarketWire
22-07-15AstraZeneca commences Phase II TrialRNS
22-06-15Synairgen resolutions passed at AGMStockMarketWire
22-06-15Result of AGMRNS
02-06-15Holding(s) in CompanyRNS
15-05-15Notice of AGMRNS
22-04-15Posting of Annual Report and AccountsRNS
05-03-15Richard Griffiths increases stake in Synairgen StockMarketWire
05-03-15Richard Griffiths increases stake to 6.1 percentRNS

RSS feeds

  • Editorial news feed for LSE:SNG Editorial
  • Regulatory news feed for LSE:SNG Regulatory